Ask HopeStage to review this study with me
Study ID: EUCTR 2005-000223-42. We help you review the study, but cannot decide medical eligibility.
OngoingEUCTR 2005-000223-42
Effects of ziprasidone vs. placebo during the first four weeks of eight weeks sertraline treatment in people with posttraumatic stress disorder (PTSD)
This study is ongoing in Germany. It focuses on PTSD.
Mental health, Post-traumatic Stress Disorder (PTSD) according to DSM-IV criteria, ...Other
Key information made simple
What is this study testing?
This study is testing whether a study medication may be useful for people experiencing mental health.
What would participation involve?
Participants may receive a study medication, complete questionnaires or follow-up assessments, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in Germany.
Who is it mainly for?
This study appears to be mainly for people with mental health.
What should you check before joining?
Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.
HopeStage note
This page is based on public study information. It does not mean the study is right for you. Check the official record and speak with the study team or a clinician before deciding.
Your next step
The public record does not provide enough detail to summarize the visit format or participation steps clearly. Check the official source for the exact eligibility criteria, locations, contact details, and current recruiting status before taking any next step.
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Ongoing
- Estimated enrollment
- Not clearly listed
- Sponsor
- University Hospital Hamburg-Eppendorf, Psychiatry
- Sponsor type
- Hospital / academic medical center
- Study type
- Other
- Intervention type
- Other / unclear
- Study phase
- Not clearly listed
- Locations
- Germany
- Age range
- Not clearly listed
- Official registry ID
- EUCTR 2005-000223-42
- Official title
- Effects of ziprasidone vs. placebo during the first four weeks of eight weeks sertraline treatment in patients with posttraumatic stress disorder (PTSD)
- Official source
- Official registry link
Want help reviewing this study?
Study ID: EUCTR 2005-000223-42. We help you review the study, but cannot decide medical eligibility.
For you
Taking part may help improve understanding of your condition.
It requires a lighter follow-up, often with questionnaires or check-ins.
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is this study trying to understand?
This study is exploring a mental health research question for people with mental health. The research team can explain what participation involves. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Why is the study type not clearly categorized?
The study type is not clearly categorized in the public registry. Focus on the objective, required tasks, visits, any intervention, and eligibility criteria, then ask the study team to confirm.
Who might this study be for?
This study may concern people with mental health. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
The public registry does not clearly describe all participation steps. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What risks or points should I check?
The public registry does not make the main risk category clear. Ask the study team what activities are required, what could feel uncomfortable, how safety is monitored, and what happens if you want to stop. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by University Hospital Hamburg-Eppendorf, Psychiatry, which appears to be a hospital or academic medical center. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The recruitment status is not clearly listed. Check the official registry or contact the study team.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me